Yüklüyor......
The progress of targeted therapy in advanced gastric cancer
Although palliative chemotherapy has been shown to prolong survival and improve quality of life, the survival of advanced gastric cancer (AGC) patients remains poor. With the advent of targeted therapy, many molecular targeted agents have been evaluated in clinical studies. Trastuzumab, an anti-HER2...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioMed Central
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3878836/ https://ncbi.nlm.nih.gov/pubmed/24330856 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2050-7771-1-32 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|